Disclosed herein is a pharmaceutical composition for reducing scar formation in a subject in need thereof. The pharmaceutical composition includes a mixture of three nucleic acids and a pharmaceutically acceptable carrier. A method for reducing scar formation in a subject in need thereof is also disclosed herein.
